<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04381182</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY19020291</org_study_id>
    <nct_id>NCT04381182</nct_id>
  </id_info>
  <brief_title>Heart Rate Variability and Stress Management Enhancement</brief_title>
  <official_title>Impact of Heart Rate Variability Modulation on Stress and Performance Among Neurosurgical Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joseph Maroon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Apollo Neuro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted by using two devices (Apollo and Biostrap) for monitoring of
      baseline physiologic variables and heart rate variability. The biostrap will be worn by
      residents and will monitor heart rate, heart rate variability, respiratory rate, sleep
      patterns, steps, etc. The Apollo is a pulse generator device aimed at modulating heart rate
      variability for (hopefully) reduction in stress and improving performance in and around the
      hospital. Resident neurosurgeons will wear the biostrap for a two week cycle and follow that
      with the addition of the Apollo device for heart rate variability modulation.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 6, 2020</start_date>
  <completion_date type="Anticipated">June 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline to two month heart rate variability</measure>
    <time_frame>Baseline, Two Month. Analyzed via paired t-test and assessing change between each outcome time point</time_frame>
    <description>Quantitative (average range, beats per minute)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to two month Perceived Stress Scale</measure>
    <time_frame>Baseline, Two Month. Analyzed via paired t-test and assessing change between each outcome time point</time_frame>
    <description>Questionnaire, 14 point form/scale ranging from 0-50 with higher scores signifiying increased stress</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to two month Quick Inventory of Depressive Symptomatology (QIDS)</measure>
    <time_frame>Baseline, Two Month. Analyzed via paired t-test and assessing change between each outcome time point</time_frame>
    <description>Questionnaire ranging from 0-27 and measuring major depressive symptomatology. Higher scores signify more severe depression.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Stress</condition>
  <condition>Heart Rate Variability</condition>
  <arm_group>
    <arm_group_label>Biostrap/Apollo Device Use</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants wear a Biostrap wearable device which measures steps, heart rate, heart rate variability, sleep metrics, and quantitative data in typical day-to-day activities of residents. Participants then again wear Biostrap except now also with the Apollo device which is worn around the ankle and is suggested to modulate heart rate variability and perceived stress of participants.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Apollo Wearable Device</intervention_name>
    <description>Participants wear Apollo device which generates vibration frequencies on skin and can be controlled by the user</description>
    <arm_group_label>Biostrap/Apollo Device Use</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neurosurgical Resident (UPMC)

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Maroon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurological Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UPMC Presbyterian Hospital Department of Neurological Surgery</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 5, 2020</study_first_submitted>
  <study_first_submitted_qc>May 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2020</study_first_posted>
  <last_update_submitted>May 5, 2020</last_update_submitted>
  <last_update_submitted_qc>May 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Joseph Maroon</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified changes in heart rate variability, de-identified changes between QIDS and PSS questionnaires.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be available at one month from study start and will be available for two months from study start.</ipd_time_frame>
    <ipd_access_criteria>Principal investigator and three additional primary study members will have access to data.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

